MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer


Submitted: 23 October 2010
Accepted: 1 December 2010
Published: 13 December 2010
Abstract Views: 3627
PDF: 548
HTML: 3265
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

miRNAs are small-noncoding RNA molecules that regulate gene expression on a posttranscriptional level. A number of oncogenes and tumor suppressors were found to be targets of miRNAs and global miRNA expression signatures were able to distinguish between cancerous and non-cancerous tissues. Therefore it was not surprising that some miRNAs could be linked to the pathogenesis of cancer. In this review we provide an overview of the use of microRNAs as diagnostic and prognostic tools in cancer and focus on the use of miRNA expression as biomarker for disease activity.

Daniela Asslaber, Laboratory for Immunological and Molecular Cancer Research, University Hospital, Salzburg
not applicable

Supporting Agencies

This work was supported by Austrian FWF grants P19481 and L488 to A.E., Austrian National Bank grant 10990 to A.E., and by the state of Salzburg and the SFB 021 to R.G.

Asslaber, D., Piñón Hofbauer, J., Greil, R., & Egle, A. (2010). MicroRNAs as biomarkers for the diagnosis and prognosis of human cancer. Journal of Nucleic Acids Investigation, 1(1), e14. https://doi.org/10.4081/jnai.2010.2130

Downloads

Download data is not yet available.

Citations